Athersys Inc

NASDAQ:ATHX  
1.03
-0.06 (-5.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)227.85M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.13 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$1.06
50-Day MA$1.23
200-Day MA$1.55
See more pivots

Athersys Inc Stock, NASDAQ:ATHX

3201 Carnegie Avenue, Cleveland, Ohio 44115-2634
United States of America
Phone: +1.216.431.9900
Number of Employees: 97

Description

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.